06/09/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/9/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Illumina COVIDSeq Test. The Illumina COVIDSeq Test is authorized for use with respiratory specimens collected from individuals who are suspected to have of COVID-19 by their healthcare provider. (PDF)
No hay comentarios:
Publicar un comentario